Literature DB >> 6882511

Suppression of cholesterogenesis and reduction of LDL cholesterol by dietary ginseng and its fractions in chicken liver.

A A Qureshi, N Abuirmeileh, Z Z Din, Y Ahmad, W C Burger, C E Elson.   

Abstract

The effects of ginseng root powder and of serially extracted solvent fractions of ginseng on avian hepatic cholesterol metabolism and lipogenesis and on avian serum lipoprotein cholesterol levels were examined. In one study, White Leghorn females were fed for 4 weeks a corn-based diet (control) or an experimental diet in which was incorporated 0.25% Wisconsin ginseng or an equivalent quantity of a serial solvent fraction [petroleum ether (PESF), methyl alcohol (MESF), water (WASF)] or of the residue. beta-hydroxy-beta-methylglutaryl-CoA (HMG-CoA) reductase activity was significantly lower (P less than 0.01) in each of the treatment groups (31-37% of control activity) except that fed the extracted residue (90% of control, N.S.). Cholesterol 7 alpha-hydroxylase activity was lowered in parallel (45-64% of control, P less than 0.01) by all treatments except the residue (100% of control). Also with the exception of the residue treatment, each ginseng treatment effected a lowering of the serum total cholesterol level (67-83% of control, P less than 0.01) and of serum low density lipoprotein cholesterol level (53-81% of control, P less than 0.01). Lipogenic activities and serum triglycerides levels were lowered (P less than 0.01) by two of the ginseng treatments. The PESF treatment was the most effective suppressor of each parameter, 74% and 68% respectively, of the control values. The WASF also had significant impact. Not one of the experimental diets influenced the serum high density lipoprotein level. The PESF, the potent source of suppressors, effected a change in the ratio of low to high density lipoprotein cholesterol from 1.46 (control) to 0.88. The levels of cholesterol and triglycerides in liver under these conditions showed a similar pattern as that of serum. In companion studies, broiler females were fed 0.28% Chinese red ginseng root powder or its various fractions. The results confirmed those recorded above. The factor(s) responsible for lowering the serum total and low density lipoprotein cholesterol levels were generally more concentrated in the PESF and WASF of ginseng and each was significantly more effective than was ginseng root powder. Ginsenosides (saponins) are considered to be the active agents for the suppression of cholesterogenesis and lipogenesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6882511     DOI: 10.1016/0021-9150(83)90019-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  14 in total

1.  Suppression of cholesterogenesis by plant constituents: review of Wisconsin contributions to NC-167.

Authors:  A A Qureshi; W C Burger; D M Peterson; C Elson
Journal:  Lipids       Date:  1985-11       Impact factor: 1.880

2.  Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.

Authors:  Michung Yoon; Hyunghee Lee; Sunhyo Jeong; Jung-Jae Kim; Christopher J Nicol; Kung Woo Nam; Moonza Kim; Byung Goo Cho; Goo Taeg Oh
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

Review 3.  Regulation of appetite-related neuropeptides by Panax ginseng: A novel approach for obesity treatment.

Authors:  Hung Manh Phung; Dongyeop Jang; Tuy An Trinh; Donghun Lee; Quynh Nhu Nguyen; Chang-Eop Kim; Ki Sung Kang
Journal:  J Ginseng Res       Date:  2022-04-04       Impact factor: 5.735

Review 4.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

5.  Astragalus polysaccharides lowers plasma cholesterol through mechanisms distinct from statins.

Authors:  Yunjiu Cheng; Kai Tang; Suhua Wu; Lijuan Liu; Cancan Qiang; Xiaoxiong Lin; Bingqing Liu
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

6.  Interaction of Veratrum nigrum with Panax ginseng against Obesity: A Sang-ban Relationship.

Authors:  Jinbong Park; Yong-Deok Jeon; Hye-Lin Kim; Hara Lim; Yunu Jung; Dong-Hyun Youn; Mi-Young Jeong; Hyun-Ju Kim; Sung-Hoon Kim; Su-Jin Kim; Seung-Heon Hong; Jae-Young Um
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-02       Impact factor: 2.629

7.  Ginseng extract and ginsenoside Rb1 attenuate carbon tetrachloride-induced liver fibrosis in rats.

Authors:  Ya-Ling Hou; Ya-Hui Tsai; Yun-Ho Lin; Jane C-J Chao
Journal:  BMC Complement Altern Med       Date:  2014-10-25       Impact factor: 3.659

8.  GABAA Receptor- and Non-NMDA Glutamate Receptor-Mediated Actions of Korean Red Ginseng Extract on the Gonadotropin Releasing Hormone Neurons.

Authors:  Dong Hyu Cho; Janardhan Prasad Bhattarai; Seong Kyu Han
Journal:  J Ginseng Res       Date:  2012-01       Impact factor: 6.060

9.  Nutritional factors affecting abdominal fat deposition in poultry: a review.

Authors:  A M Fouad; H K El-Senousey
Journal:  Asian-Australas J Anim Sci       Date:  2014-07       Impact factor: 2.509

Review 10.  Ginseng and obesity.

Authors:  Zhipeng Li; Geun Eog Ji
Journal:  J Ginseng Res       Date:  2017-01-10       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.